Cargando…
Clinical features, therapeutic outcomes, and recovery period of long COVID
To characterize the clinical features of long COVID, 286 patients who received care in our outpatient clinic for long COVID from May to December 2021 were surveyed. The recovery periods of each symptom and the key factors contributing to early recovery were statistically analysed. The median age of...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108287/ https://www.ncbi.nlm.nih.gov/pubmed/36412057 http://dx.doi.org/10.1002/jmv.28316 |
_version_ | 1785026820130734080 |
---|---|
author | Takakura, Kazuki Suka, Machi Kajihara, Mikio Koido, Shigeo |
author_facet | Takakura, Kazuki Suka, Machi Kajihara, Mikio Koido, Shigeo |
author_sort | Takakura, Kazuki |
collection | PubMed |
description | To characterize the clinical features of long COVID, 286 patients who received care in our outpatient clinic for long COVID from May to December 2021 were surveyed. The recovery periods of each symptom and the key factors contributing to early recovery were statistically analysed. The median age of the patients was 35.8 years, with 137 men and 149 women. The median number of symptoms was 2.8. The most frequent symptoms were respiratory manifestations (52.1%), followed by fatigue (51.4%). Respiratory symptoms, fatigue, and headache/arthralgia were major complaints in the initial phase, whereas hair loss was a major complaint in the late phase, suggesting that the chief complaint of patients with long COVID may vary temporally. The best treatment outcome was observed for pulmonary symptoms, and hair loss had the worst outcome. COVID‐19 severity, the number of manifestations, and the delay in starting treatment exerted a negative effect on the recovery period of long COVID. In addition, the smoking habit was an independent risk factor for slowing the recovery period from long COVID. This study provides insights into the clinical course of each manifestation and therapeutic options with a more certain future of long COVID to meet the unmet medical needs. |
format | Online Article Text |
id | pubmed-10108287 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101082872023-04-18 Clinical features, therapeutic outcomes, and recovery period of long COVID Takakura, Kazuki Suka, Machi Kajihara, Mikio Koido, Shigeo J Med Virol Research Articles To characterize the clinical features of long COVID, 286 patients who received care in our outpatient clinic for long COVID from May to December 2021 were surveyed. The recovery periods of each symptom and the key factors contributing to early recovery were statistically analysed. The median age of the patients was 35.8 years, with 137 men and 149 women. The median number of symptoms was 2.8. The most frequent symptoms were respiratory manifestations (52.1%), followed by fatigue (51.4%). Respiratory symptoms, fatigue, and headache/arthralgia were major complaints in the initial phase, whereas hair loss was a major complaint in the late phase, suggesting that the chief complaint of patients with long COVID may vary temporally. The best treatment outcome was observed for pulmonary symptoms, and hair loss had the worst outcome. COVID‐19 severity, the number of manifestations, and the delay in starting treatment exerted a negative effect on the recovery period of long COVID. In addition, the smoking habit was an independent risk factor for slowing the recovery period from long COVID. This study provides insights into the clinical course of each manifestation and therapeutic options with a more certain future of long COVID to meet the unmet medical needs. John Wiley and Sons Inc. 2022-12-02 2023-01 /pmc/articles/PMC10108287/ /pubmed/36412057 http://dx.doi.org/10.1002/jmv.28316 Text en © 2022 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Research Articles Takakura, Kazuki Suka, Machi Kajihara, Mikio Koido, Shigeo Clinical features, therapeutic outcomes, and recovery period of long COVID |
title | Clinical features, therapeutic outcomes, and recovery period of long COVID |
title_full | Clinical features, therapeutic outcomes, and recovery period of long COVID |
title_fullStr | Clinical features, therapeutic outcomes, and recovery period of long COVID |
title_full_unstemmed | Clinical features, therapeutic outcomes, and recovery period of long COVID |
title_short | Clinical features, therapeutic outcomes, and recovery period of long COVID |
title_sort | clinical features, therapeutic outcomes, and recovery period of long covid |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108287/ https://www.ncbi.nlm.nih.gov/pubmed/36412057 http://dx.doi.org/10.1002/jmv.28316 |
work_keys_str_mv | AT takakurakazuki clinicalfeaturestherapeuticoutcomesandrecoveryperiodoflongcovid AT sukamachi clinicalfeaturestherapeuticoutcomesandrecoveryperiodoflongcovid AT kajiharamikio clinicalfeaturestherapeuticoutcomesandrecoveryperiodoflongcovid AT koidoshigeo clinicalfeaturestherapeuticoutcomesandrecoveryperiodoflongcovid |